Jones said in an investor note that Carvana has enough cash and strong value proposition.Good morning Wake-Up Watchlisters! While you're cringing at the gas pump odometer you'll see stock futures started the second half of 2022 on a down note. Same old story – more recession concerns caused the slide. However, bond markets are starting to steady. With markets trading at discounted levels, we want to offer the same value for our readers. So starting today… we're offering a $500 discount on The War Room. We've recorded gains as high as 246% during the COVID crash and our short-term trades have a 90% win rate in 2022. To get the $500 discount, just enter the code 'WAR.' Click here to get these trades and save $500 today. Here's a look at the top-moving stocks this morning. Carvana (NYSE: CVNA)Carvana is up 5.58% premarket following positive news from an analyst. JMP Securities analyst Ncholas Jones resumed coverage of the company and put a $35 price target on its stock. Jones said in an investor note that Carvana has enough cash, strong value proposition and still has a lot to offer automotive consumers – including a large selection and positive buying experience. Keep an eye on Carvana going forward. Kohl's (NYSE: KSS)Kohl's is down 12.16% premarket after a potential buyout from Franchise Group ended without a deal. The takeover was estimated at $8 billion, but talks ceased after reports that Franchise Group was looking to reduce its bid for Kohl's by $10, to $50 a share. Kohl's stock is looking uncertain. Invesco (NYSE: IVZ)Invesco is up 8.18% premarket as volatility ETF's are benefiting from choppy global markets. Invesco was among the best-performing ETF's of Q2, and recently increased its monthly dividend to common shareholders. The Federal Reserve's recent rate hikes boosted the value of greenback in Q2, and Invesco DB US Dollar Index has been up 5.2% over the past three months. Keep an eye on Invesco going forward. Mirati Therapeutics (Nasdaq: MRTX)Mirati Therapeutics Inc. is up 6.08% premarket as the Virtus LifeSci Biotech Clinical Trials ETF was among the best-performing U.S. equity ETFs in June, gaining about 10%. The steep sell-off in the stock market led to a huge decline in biotech stocks, and investors have been feasting on the bargains ever since. Mirati was one among a few that gained more than 45% this year. Overall, the stock soared 71.7% in June. Keep an eye on Mirati Therapeutics. The medical industry is innovating at a rapid rate, and there's a major development thanks to Tesla and SpaceX CEO Elon Musk. Musk recently sent a new medical invention into orbit – and right now Oxford Club Chief Investment Strategist Alexander Green says you can invest in its technology for just $3. Click here to unlock this $3 stock. The Most Important Investing Concept for This Market We're in a bear market, and our Head Fundamental Tactitican Karim Rahemtulla shows you how to invest in the market without losing your money. This is critical as bear markets offer the highest potential return on investments. Click here to watch the video. Those are the top market movers today. Happy trading! The Wake-Up Watchlist Research Team | 
No comments:
Post a Comment